{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:05:22Z","timestamp":1779357922918,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160385"],"award-info":[{"award-number":["82160385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82273694"],"award-info":[{"award-number":["82273694"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Guangxi Zhuang AutonomousRegion","award":["2024GXNSFBA010104"],"award-info":[{"award-number":["2024GXNSFBA010104"]}]},{"name":"Natural Science Foundation of Guangxi Zhuang AutonomousRegion","award":["2023GXNSFDA026036"],"award-info":[{"award-number":["2023GXNSFDA026036"]}]},{"name":"Guangxi Zhuang Autonomous Region \"Qingmiao\" Talent Funding Research Project"},{"name":"Science and Technology Project for Disease Control and Prevention of Guangxi Zhuang Autonomous Region","award":["GXJKKJ2025ZC004"],"award-info":[{"award-number":["GXJKKJ2025ZC004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver cirrhosis (LC) is a chronic liver disease with global prevalence. Current diagnostic methods for LC still face limitations in safety and accessibility. We aimed to develop an interpretable machine learning (ML) prediction model for LC using gut microbes and deploy it as a web-based clinical decision support tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were retrieved from PubMed and BioProject databases. Bioinformatics re-analysis and discriminant analysis effect size (LEfSe) analysis was conducted to preliminarily identify key genera associated with LC. Further feature selection was performed using Least Absolute Shrinkage and Selection Operator (LASSO) regression. The independent datasets were combined to form an integrated dataset, which was then subjected to five-fold cross-validation and leave-one-dataset-out (LODO) analysis. Model performance was evaluated using metrics such as the area under the receiver operating characteristic curve (AUC), and the optimal model was selected. The decision mechanism of the optimal model was interpreted using SHapley Additive exPlanations (SHAP), and the model was deployed as a web application using the Streamlit framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We ultimately included 11 datasets related to LC. The genera\n                      <jats:italic>Veillonella<\/jats:italic>\n                      ,\n                      <jats:italic>Lachnospira<\/jats:italic>\n                      ,\n                      <jats:italic>Romboutsia<\/jats:italic>\n                      ,\n                      <jats:italic>Akkermansia<\/jats:italic>\n                      ,\n                      <jats:italic>Erysipelatoclostridium<\/jats:italic>\n                      ,\n                      <jats:italic>Prevotella<\/jats:italic>\n                      ,\n                      <jats:italic>UCG.005<\/jats:italic>\n                      , and\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      were identified as key predictors distinguishing LC patients from healthy controls. The Random Forest (RF) model demonstrated the best predictive performance (AUC in five-fold cross-validation: 0.875, 95% CI: 0.823\u20130.905; AUC in LODO analysis: 0.793, 95% CI: 0.702\u20130.940) and was deployed as an online LC prediction tool.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The interpretable RF model, along with its web-based implementation, has the potential to provide decision support for healthcare professionals and shows promise as a valuable auxiliary tool for LC screening and early clinical intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-026-04890-7","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:04:22Z","timestamp":1778047462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning-driven clinical decision support for liver cirrhosis: a gut microbiome-based web prediction model with explainable AI integration"],"prefix":"10.1186","volume":"26","author":[{"given":"Jianyuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiran","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanzhuo","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuyan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiegang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"4","key":"4890_CR1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.mcna.2009.03.002","volume":"93","author":"HB Lefton","year":"2009","unstructured":"Lefton HB, Rosa A, Cohen M. Diagnosis and epidemiology of cirrhosis. Med Clin North Am. 2009;93(4):787\u201399.","journal-title":"Med Clin North Am"},{"issue":"10308","key":"4890_CR2","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359\u201376.","journal-title":"Lancet"},{"issue":"3","key":"4890_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(3):516\u201337.","journal-title":"J Hepatol"},{"issue":"3","key":"4890_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/cam4.1998","volume":"8","author":"K Tarao","year":"2019","unstructured":"Tarao K, et al. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment. Cancer Med. 2019;8(3):1054\u201365.","journal-title":"Cancer Med"},{"issue":"2","key":"4890_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/gastro\/gox012","volume":"5","author":"B Procopet","year":"2017","unstructured":"Procopet B, Berzigotti A. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf). 2017;5(2):79\u201389.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"8","key":"4890_CR6","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1007\/s10620-021-07089-w","volume":"67","author":"HB Thomaides-Brears","year":"2022","unstructured":"Thomaides-Brears HB, et al. Incidence of complications from percutaneous biopsy in chronic liver disease: a systematic review and meta-analysis. Dig Dis Sci. 2022;67(8):3366\u201394.","journal-title":"Dig Dis Sci"},{"key":"4890_CR7","doi-asserted-by":"publisher","first-page":"1497095","DOI":"10.3389\/fimmu.2025.1497095","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, et al. The role of the interleukin family in liver fibrosis. Front Immunol. 2025;16:1497095.","journal-title":"Front Immunol"},{"issue":"5","key":"4890_CR8","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1053\/j.gastro.2024.08.046","volume":"168","author":"B McGettigan","year":"2025","unstructured":"McGettigan B, Hernandez-Tejero M, Malhi H, Shah V. Immune dysfunction and infection risk in advanced liver disease. Gastroenterology. 2025;168(5):1085\u2013100.","journal-title":"Gastroenterology"},{"issue":"1","key":"4890_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella E, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7(1):14.","journal-title":"Microorganisms"},{"issue":"4","key":"4890_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41423-021-00661-4","volume":"18","author":"W Yang","year":"2021","unstructured":"Yang W, Cong Y. Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases. Cell Mol Immunol. 2021;18(4):866\u201377.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"4890_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020;72(3):558\u201377.","journal-title":"J Hepatol"},{"issue":"2","key":"4890_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cgh.2018.08.008","volume":"17","author":"C Acharya","year":"2019","unstructured":"Acharya C, Bajaj JS. The microbiome in cirrhosis and its complications. Clin Gastroenterol Hepatol. 2019;17(2):307\u201321.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"4890_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/ijms26020527","volume":"26","author":"E Xirouchakis","year":"2025","unstructured":"Xirouchakis E, et al. A systematic review of microbiota in cirrhosis: a change towards a more pathogenic predisposition. Int J Mol Sci. 2025;26(2):527.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4890_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12876-025-03589-5","volume":"25","author":"Y Liu","year":"2025","unstructured":"Liu Y, et al. Associations between changes in the gut microbiota and liver cirrhosis: a systematic review and meta-analysis. BMC Gastroenterol. 2025;25(1):16.","journal-title":"BMC Gastroenterol"},{"issue":"7516","key":"4890_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin N, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513(7516):59\u201364.","journal-title":"Nature"},{"issue":"1","key":"4890_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/j.gastro.2020.08.054","volume":"160","author":"C Sol\u00e9","year":"2021","unstructured":"Sol\u00e9 C, et al. Alterations in gut microbiome in cirrhosis as assessed by quantitative metagenomics: relationship with acute-on-chronic liver failure and prognosis. Gastroenterology. 2021;160(1):206\u2013e21813.","journal-title":"Gastroenterology"},{"issue":"5","key":"4890_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","volume":"32","author":"TG Oh","year":"2020","unstructured":"Oh TG, et al. A universal gut-microbiome-derived signature predicts cirrhosis. Cell Metab. 2020;32(5):878\u2013e8886.","journal-title":"Cell Metab"},{"issue":"12","key":"4890_CR18","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.3390\/ijerph15122796","volume":"15","author":"K Benke","year":"2018","unstructured":"Benke K, Benke G. Artificial intelligence and big data in public health. Int J Environ Res Public Health. 2018;15(12):2796.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"4890_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12911-023-02402-1","volume":"23","author":"X Liu","year":"2023","unstructured":"Liu X, Liu D, Tan C, Feng W. Gut microbiome-based machine learning for diagnostic prediction of liver fibrosis and cirrhosis: a systematic review and meta-analysis. BMC Med Inf Decis Mak. 2023;23(1):294.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"1","key":"4890_CR20","doi-asserted-by":"publisher","first-page":"16122","DOI":"10.1038\/s41598-024-60768-2","volume":"14","author":"IG Park","year":"2024","unstructured":"Park IG, et al. Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease. Sci Rep. 2024;14(1):16122.","journal-title":"Sci Rep"},{"issue":"7\u20138","key":"4890_CR21","doi-asserted-by":"publisher","first-page":"105368","DOI":"10.1016\/j.micinf.2024.105368","volume":"26","author":"Q Wang","year":"2024","unstructured":"Wang Q, et al. Machine learning-based characterization of the gut microbiome associated with the progression of primary biliary cholangitis to cirrhosis. Microbes Infect. 2024;26(7\u20138):105368.","journal-title":"Microbes Infect"},{"issue":"1","key":"4890_CR22","doi-asserted-by":"publisher","first-page":"9385","DOI":"10.1038\/s41598-020-66241-0","volume":"10","author":"S Lang","year":"2020","unstructured":"Lang S, et al. Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools. Sci Rep. 2020;10(1):9385.","journal-title":"Sci Rep"},{"key":"4890_CR23","unstructured":"PubMed. March. https:\/\/pubmed.ncbi.nlm.nih.gov\/. Accessed 7 2026."},{"key":"4890_CR24","unstructured":"BioProject. https:\/\/www.ncbi.nlm.nih.gov\/bioproject. Accessed 7 March 2026."},{"key":"4890_CR25","unstructured":"SRA Toolkit. https:\/\/github.com\/ncbi\/sratoolkit. Accessed 7 March 2026."},{"issue":"1","key":"4890_CR26","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1002\/cpbi.100","volume":"70","author":"M Estaki","year":"2020","unstructured":"Estaki M, et al. QIIME 2 enables comprehensive end-to-end analysis of diverse microbiome data and comparative studies with publicly available data. Curr Protoc Bioinf. 2020;70(1):e100.","journal-title":"Curr Protoc Bioinf"},{"key":"4890_CR27","doi-asserted-by":"publisher","first-page":"1257903","DOI":"10.3389\/fmicb.2023.1257903","volume":"14","author":"H Mai","year":"2024","unstructured":"Mai H, Yang X, Xie Y, et al. The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease. Front Microbiol. 2024;14:1257903.","journal-title":"Front Microbiol"},{"issue":"1","key":"4890_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40168-018-0470-z","volume":"6","author":"NA Bokulich","year":"2018","unstructured":"Bokulich NA, et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2\u2019s q2-feature-classifier plugin. Microbiome. 2018;6(1):90.","journal-title":"Microbiome"},{"issue":"2","key":"4890_CR29","doi-asserted-by":"publisher","first-page":"fiaa255","DOI":"10.1093\/femsec\/fiaa255","volume":"97","author":"C Liu","year":"2021","unstructured":"Liu C, Cui Y, Li X, Yao M. microeco: an R package for data mining in microbial community ecology. FEMS Microbiol Ecol. 2021;97(2):fiaa255.","journal-title":"FEMS Microbiol Ecol"},{"issue":"2","key":"4890_CR30","doi-asserted-by":"publisher","first-page":"e0035423","DOI":"10.1128\/msphere.00354-23","volume":"9","author":"PD Schloss","year":"2024","unstructured":"Schloss PD. Rarefaction is currently the best approach to control for uneven sequencing effort in amplicon sequence analyses. mSphere. 2024;9(2):e0035423.","journal-title":"mSphere"},{"issue":"6","key":"4890_CR31","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.","journal-title":"Genome Biol"},{"issue":"1","key":"4890_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40793-020-00358-7","volume":"15","author":"F Wemheuer","year":"2020","unstructured":"Wemheuer F, et al. Tax4Fun2: prediction of habitat-specific functional profiles and functional redundancy based on 16S rRNA gene sequences. Environ Microbiome. 2020;15(1):11.","journal-title":"Environ Microbiome"},{"issue":"D1","key":"4890_CR33","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 2025;53(D1):D672\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4890_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4890_CR35","doi-asserted-by":"publisher","first-page":"bbac622","DOI":"10.1093\/bib\/bbac622","volume":"24","author":"Y Wang","year":"2023","unstructured":"Wang Y, Le Cao KA. PLSDA-batch: a multivariate framework to correct for batch effects in microbiome data. Brief Bioinform. 2023;24(1):bbac622.","journal-title":"Brief Bioinform"},{"issue":"1","key":"4890_CR36","doi-asserted-by":"publisher","first-page":"2392880","DOI":"10.1080\/19490976.2024.2392880","volume":"16","author":"JS Bajaj","year":"2024","unstructured":"Bajaj JS, et al. Gut microbiome profiles to exclude the diagnosis of hepatic encephalopathy in patients with cirrhosis. Gut Microbes. 2024;16(1):2392880.","journal-title":"Gut Microbes"},{"issue":"2","key":"4890_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-2753.2005.00598.x","volume":"12","author":"A Linden","year":"2006","unstructured":"Linden A. Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis. J Eval Clin Pract. 2006;12(2):132\u20139.","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"4890_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13040-021-00244-z","volume":"14","author":"D Chicco","year":"2021","unstructured":"Chicco D, T\u00f6tsch N, Jurman G. The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation. BioData Min. 2021;14(1):13.","journal-title":"BioData Min"},{"issue":"703","key":"4890_CR39","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/qj.2985","volume":"143","author":"S Siegert","year":"2017","unstructured":"Siegert S. Simplifying and generalising Murphy\u2019s Brier score decomposition. Q J R Meteorol Soc. 2017;143(703):1178\u201383.","journal-title":"Q J R Meteorol Soc"},{"issue":"6","key":"4890_CR40","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","volume":"74","author":"B Van Calster","year":"2018","unstructured":"Van Calster B, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74(6):796\u2013804.","journal-title":"Eur Urol"},{"key":"4890_CR41","unstructured":"Streamlit. March. https:\/\/docs.streamlit.io\/. Accessed 7 2026."},{"key":"4890_CR42","doi-asserted-by":"publisher","first-page":"1560564","DOI":"10.3389\/fcimb.2025.1560564","volume":"15","author":"K Shi","year":"2025","unstructured":"Shi K, Sun L, Feng Y, Wang X. Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progression. Front Cell Infect Microbiol. 2025;15:1560564.","journal-title":"Front Cell Infect Microbiol"},{"key":"4890_CR43","doi-asserted-by":"publisher","first-page":"1674838","DOI":"10.3389\/fimmu.2025.1674838","volume":"16","author":"X Sun","year":"2025","unstructured":"Sun X, Zhou Z, Chi X, et al. Featured intestinal microbiota associated with hepatocellular carcinoma in various liver disease states. Front Immunol. 2025;16:1674838.","journal-title":"Front Immunol"},{"issue":"1","key":"4890_CR44","doi-asserted-by":"publisher","first-page":"8394","DOI":"10.1038\/s41598-025-92618-0","volume":"15","author":"K Gulyaeva","year":"2025","unstructured":"Gulyaeva K, et al. Gut microbiota analysis in cirrhosis and non-cirrhotic portal hypertension suggests that portal hypertension can be main factor of cirrhosis-specific dysbiosis. Sci Rep. 2025;15(1):8394.","journal-title":"Sci Rep"},{"key":"4890_CR45","doi-asserted-by":"publisher","first-page":"916061","DOI":"10.3389\/fmicb.2022.916061","volume":"13","author":"R Li","year":"2022","unstructured":"Li R, et al. Gut microbiome signatures in the progression of hepatitis B virus-induced liver disease. Front Microbiol. 2022;13:916061.","journal-title":"Front Microbiol"},{"key":"4890_CR46","doi-asserted-by":"publisher","first-page":"649060","DOI":"10.3389\/fcimb.2021.649060","volume":"11","author":"X Zhong","year":"2021","unstructured":"Zhong X, et al. Streptococcus, the predominant bacterium to predict the severity of liver injury in alcoholic liver disease. Front Cell Infect Microbiol. 2021;11:649060.","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"4890_CR47","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1002\/cam4.3045","volume":"9","author":"R Zheng","year":"2020","unstructured":"Zheng R, et al. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma. Cancer Med. 2020;9(12):4232\u201350.","journal-title":"Cancer Med"},{"key":"4890_CR48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fmicb.2020.00383","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, et al. Featured gut microbiomes associated with the progression of chronic hepatitis B disease. Front Microbiol. 2020;11:383.","journal-title":"Front Microbiol"},{"issue":"1","key":"4890_CR49","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","volume":"10","author":"C Caussy","year":"2019","unstructured":"Caussy C, et al. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. Nat Commun. 2019;10(1):1406.","journal-title":"Nat Commun"},{"key":"4890_CR50","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fphys.2018.00470","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu Y, et al. Small bowel transit and altered gut microbiota in patients with liver cirrhosis. Front Physiol. 2018;9:470.","journal-title":"Front Physiol"},{"issue":"1","key":"4890_CR51","doi-asserted-by":"publisher","first-page":"8210","DOI":"10.1038\/s41598-018-26509-y","volume":"8","author":"V Iebba","year":"2018","unstructured":"Iebba V, et al. Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy. Sci Rep. 2018;8(1):8210.","journal-title":"Sci Rep"},{"key":"4890_CR52","unstructured":"The online web-based application for predicting liver cirrhosis. https:\/\/e4dhmelybbi8vlgv8nyknn.streamlit.app\/. Accessed 7 March 2026."},{"key":"4890_CR53","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.3389\/fmicb.2019.02407","volume":"10","author":"AD Willis","year":"2019","unstructured":"Willis AD. Rarefaction, alpha diversity, and statistics. Front Microbiol. 2019;10:2407.","journal-title":"Front Microbiol"},{"issue":"12","key":"4890_CR54","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/jamapsychiatry.2021.2573","volume":"78","author":"VL Nikolova","year":"2021","unstructured":"Nikolova VL, et al. Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis. JAMA Psychiatry. 2021;78(12):1343\u201354.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"4890_CR55","doi-asserted-by":"publisher","first-page":"16828","DOI":"10.1038\/s41598-025-01761-1","volume":"15","author":"J Ding","year":"2025","unstructured":"Ding J, Du J, Wang H, Xiao S. A novel two-stage feature selection method based on random forest and improved genetic algorithm for enhancing classification in machine learning. Sci Rep. 2025;15(1):16828.","journal-title":"Sci Rep"},{"key":"4890_CR56","doi-asserted-by":"publisher","first-page":"109170","DOI":"10.1016\/j.cmpb.2025.109170","volume":"274","author":"Z Liu","year":"2026","unstructured":"Liu Z, Du J, Luo J, Yuan Y, Huang Q, He J. A stable feature selection method based on majority voting and SHAP for high-dimensional metabolomics data. Comput Methods Programs Biomed. 2026;274:109170.","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"4890_CR57","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41420-022-01015-3","volume":"8","author":"Z Zhan","year":"2022","unstructured":"Zhan Z, et al. Overabundance of Veillonella parvula promotes intestinal inflammation by activating macrophages via LPS-TLR4 pathway. Cell Death Discov. 2022;8(1):251.","journal-title":"Cell Death Discov"},{"key":"4890_CR58","doi-asserted-by":"publisher","first-page":"1597145","DOI":"10.3389\/fmicb.2025.1597145","volume":"16","author":"P Qi","year":"2025","unstructured":"Qi P, Yang XX, Wang CK, Sang W, Zhang W, Bai Y. Analysis of gut and circulating microbiota characteristics in patients with liver cirrhosis and portal vein thrombosis. Front Microbiol. 2025;16:1597145.","journal-title":"Front Microbiol"},{"issue":"1","key":"4890_CR59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41522-024-00564-y","volume":"10","author":"N Oguri","year":"2024","unstructured":"Oguri N, Miyoshi J, Nishinarita Y, et al. Akkermansia muciniphila in the small intestine improves liver fibrosis in a murine liver cirrhosis model. NPJ Biofilms Microbiomes. 2024;10(1):81.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"4890_CR60","doi-asserted-by":"publisher","first-page":"1256874","DOI":"10.3389\/fmicb.2023.1256874","volume":"14","author":"QA Xiao","year":"2023","unstructured":"Xiao QA, Yang YF, Chen L, et al. The causality between gut microbiome and liver cirrhosis: a bi-directional two-sample Mendelian randomization analysis. Front Microbiol. 2023;14:1256874.","journal-title":"Front Microbiol"},{"issue":"4","key":"4890_CR61","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.3390\/ijms25041988","volume":"25","author":"I Efremova","year":"2024","unstructured":"Efremova I, Maslennikov R, Poluektova E, et al. Gut microbiota and biomarkers of endothelial dysfunction in cirrhosis. Int J Mol Sci. 2024;25(4):1988.","journal-title":"Int J Mol Sci"},{"key":"4890_CR62","doi-asserted-by":"publisher","first-page":"1568672","DOI":"10.3389\/fmicb.2025.1568672","volume":"16","author":"H Yuan","year":"2025","unstructured":"Yuan H, Zhou J, Wu X, Wang S, Park S. Enterotype-stratified gut microbial signatures in MASLD and cirrhosis based on integrated microbiome data. Front Microbiol. 2025;16:1568672.","journal-title":"Front Microbiol"},{"key":"4890_CR63","doi-asserted-by":"publisher","first-page":"1362139","DOI":"10.3389\/fgene.2024.1362139","volume":"15","author":"N Li","year":"2024","unstructured":"Li N, Chen X, Xiong S, et al. Causal impact of gut microbiota on five liver diseases: insights from Mendelian randomization and single-cell RNA sequencing. Front Genet. 2024;15:1362139.","journal-title":"Front Genet"},{"key":"4890_CR64","doi-asserted-by":"publisher","first-page":"632059","DOI":"10.3389\/fbioe.2021.632059","volume":"9","author":"S Mishra","year":"2021","unstructured":"Mishra S, et al. Recent advanced technologies for the characterization of xenobiotic-degrading microorganisms and microbial communities. Front Bioeng Biotechnol. 2021;9:632059.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"4890_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-2277.2003.tb00215.x","volume":"16","author":"UJF Tietge","year":"2003","unstructured":"Tietge UJF, Bahr MJ, Manns MP, B\u00f6ker KHW. Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation. Transpl Int. 2003;16(1):1\u20138.","journal-title":"Transpl Int"},{"issue":"1","key":"4890_CR66","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3748\/wjg.v22.i1.72","volume":"22","author":"CG Dietrich","year":"2016","unstructured":"Dietrich CG, G\u00f6tze O, Geier A. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World J Gastroenterol. 2016;22(1):72\u201388.","journal-title":"World J Gastroenterol"},{"key":"4890_CR67","doi-asserted-by":"crossref","unstructured":"Liu Y, Wang Y, Zhang J. New machine learning algorithm: Random Forest. In: International Conference on Information Computing and Applications. Springer, Berlin, Heidelberg; 2012. pp. 246\u2009\u2013\u200952.","DOI":"10.1007\/978-3-642-34062-8_32"},{"key":"4890_CR68","doi-asserted-by":"publisher","first-page":"118146","DOI":"10.1016\/j.cca.2024.118146","volume":"558","author":"J Vega Benjumea","year":"2024","unstructured":"Vega Benjumea J, et al. ELF \u2013 Enhanced Liver Fibrosis test (Siemens Healthineers) demonstrates an incremental sensitivity and specificity directly proportional to the degree of fibrosis. Clin Chim Acta. 2024;558:118146.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"4890_CR69","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2337\/ds25-0028","volume":"38","author":"SH Kim","year":"2025","unstructured":"Kim SH, et al. Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes: Are We Doing Enough? Diabetes Spectr. 2025;38(4):496\u2013501.","journal-title":"Diabetes Spectr"},{"issue":"5","key":"4890_CR70","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4166\/kjg.2024.120","volume":"84","author":"MN Kim","year":"2024","unstructured":"Kim MN. Noninvasive Imaging Test to Assess Liver Fibrosis: Vibration-controlled Transient Elastography. Korean J Gastroenterol. 2024;84(5):201\u20135.","journal-title":"Korean J Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04890-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04890-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04890-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:08:08Z","timestamp":1779354488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04890-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4890"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04890-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}